GlassScriptPhysician profile
Joseph Savarese
NPI 1700200953
$1,249.34
in general payments reported to CMS, 2019-2025
18 companies · $16.48 in 2025
The $16.48 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.67 · 2020: $11.35 · 2021: $157 · 2022: $617 · 2023: $276 · 2024: $141 · 2025: $16.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $350.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.82 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $134.25 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $89.11 | 2019-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $65.76 | 2021 | |
| Alexion Pharmaceuticals, INC. | $49.83 | 2022 | |
| Abbvie INC. | $48.41 | 2021-2023 | Dalvance |
| Merck Sharp & Dohme LLC | $48.17 | 2023 | Verquvo, Dificid, Zerbaxa |
| Pfizer INC. | $47.55 | 2020-2025 | |
| Boston Scientific Corporation | $45.17 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.50 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.32 | 2023 | Camzyos |
| Philips North America LLC | $31.45 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.46 | 2022 | |
| Amgen INC. | $22.59 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.35 | 2023 | Hillrom - Life 2000 Ventilation System |
| Gilead Sciences, INC. | $17.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Savarese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.